AAV6.2: An efficient and safe gene therapy clinical candidate for the treatment of cystic fibrosis airway disease

被引：0
|
作者：
Limberis, M. [1 ]
Vandenberghe, L. H. [1 ]
Zhang, L. [2 ]
Pickles, R. J. [2 ]
Wilson, J. M. [1 ]
机构：
[1] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[2] Univ N Carolina, Csyt Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27515 USA
来源：
PEDIATRIC PULMONOLOGY | 2007年
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
273
引用
收藏
页码：298 / 298
页数：1
相关论文
共 50 条
  • [31] Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B
    Brown, Harrison C.
    Doering, Christopher B.
    Herzog, Roland W.
    Ling, Chen
    Markusic, David M.
    Spencer, H. Trent
    Srivastava, Alok
    Srivastava, Arun
    HUMAN GENE THERAPY, 2020, 31 (19-20) : 1114 - 1123
  • [32] Lentiviral Airway Gene Therapy Correction of CFTR Function in Knockout Cystic Fibrosis Rats
    Reyne, Nikki
    Cmielewski, Patricia
    McCarron, Alexandra
    Parsons, David
    Donnelley, Martin
    MOLECULAR THERAPY, 2021, 29 (04) : 259 - 259
  • [33] Development of a Clinically-Acceptable Lentiviral Vector for Cystic Fibrosis Airway Gene Therapy
    McCarron, Alexandra
    McIntyre, Chantelle
    Donnelley, Martin
    Cmielewski, Patricia
    Parsons, David
    MOLECULAR THERAPY, 2016, 24 : S280 - S281
  • [34] Intracisternal delivery of an AAV gene therapy candidate for the treatment of GM1 Gangliosidosis
    Hocquemiller, M.
    Giersch, L.
    Deneux, M.
    Olivier, S.
    Parker, S.
    Laufer, R.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A11 - A11
  • [35] Gene therapy for cystic fibrosis: from basic research to clinical impact
    Hyde, Stephen
    HUMAN GENE THERAPY, 2013, 24 (05) : A11 - A11
  • [36] Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments
    Guggino, William B.
    Cebotaru, Liudmila
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (10) : 1265 - 1273
  • [37] GENE-THERAPY OF CYSTIC-FIBROSIS LUNG-DISEASE
    ENGELHARDT, JF
    WILSON, JM
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 : 165 - 167
  • [38] The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy
    Lommatzsch, Sherstin T.
    Taylor-Cousar, Jennifer L.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2019, 13
  • [39] Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis
    Carmody, Lisa A.
    Caverly, Lindsay J.
    Foster, Bridget K.
    Rogers, Mary A. M.
    Kalikin, Linda M.
    Simon, Richard H.
    VanDevanter, Donald R.
    LiPuma, John J.
    PLOS ONE, 2018, 13 (03):
  • [40] AIRWAY HYPERREACTIVITY IN CYSTIC-FIBROSIS - CLINICAL CORRELATES AND POSSIBLE EFFECTS ON THE COURSE OF THE DISEASE
    EGGLESTON, PA
    ROSENSTEIN, BJ
    STACKHOUSE, CM
    ALEXANDER, MF
    CHEST, 1988, 94 (02) : 360 - 365
12345